OMI has been the subject of a number of other reports. Bank of America reissued a “neutral” rating and issued a $4.50 price target (down from $7.00) on shares of Owens & Minor in a research note on Wednesday, April 10th. Zacks Investment Research raised shares of Owens & Minor from a “hold” rating to a “buy” rating and set a $3.25 price target for the company in a research note on Friday, July 19th. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $6.13.
Shares of NYSE:OMI traded up $0.06 during midday trading on Thursday, hitting $2.88. 957,865 shares of the stock traded hands, compared to its average volume of 831,703. The stock has a market cap of $170.56 million, a PE ratio of 2.50, a PEG ratio of 1.29 and a beta of 1.74. The stock’s 50 day simple moving average is $2.95. The company has a debt-to-equity ratio of 3.67, a current ratio of 1.75 and a quick ratio of 0.89. Owens & Minor has a one year low of $2.43 and a one year high of $19.16.
Hedge funds have recently added to or reduced their stakes in the stock. FMR LLC raised its stake in Owens & Minor by 159,300.0% in the fourth quarter. FMR LLC now owns 4,782 shares of the company’s stock worth $30,000 after buying an additional 4,779 shares in the last quarter. Atlantic Union Bankshares Corp purchased a new stake in Owens & Minor in the second quarter worth about $36,000. First Trust Advisors LP purchased a new stake in Owens & Minor in the first quarter worth about $56,000. First Allied Advisory Services Inc. purchased a new stake in Owens & Minor in the fourth quarter worth about $71,000. Finally, Everence Capital Management Inc. purchased a new stake in Owens & Minor in the first quarter worth about $93,000. 89.75% of the stock is owned by institutional investors.
Owens & Minor Company Profile
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers.
Recommended Story: What is meant by buying and selling pressure?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Owens & Minor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor and related companies with MarketBeat.com's FREE daily email newsletter.